Chengdu Easton Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms in anesthetic/analgesics, cardiovascular, oncology, pediatrics, and other therapeutic fields. It also offers active pharmaceutical ingredients in oncology, cardiovascular, anesthetic/analgesics, anti-inflammatory, gastrointestinal, antiemetic, neurology/psychiatry , and urinary system therapeutic categories. The company was founded in 2009 and is based in Chengdu, China.

Company Data

Name Chengdu Easton Biopharmaceuticals Co., Ltd.

Company Chengdu Easton Biopharmaceuticals Co., Ltd.

Website https://www.eastonpharma.cn

Primary Exchange

SSE

ISIN CNE100004397

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mingxu Yuan

Market Capitalization 10 Mrd.

Country China

Currency CNY

Employees 1,4 T

Address No.8, Xiyuan Avenue, 611731 Chengdu

IPO Date 2020-09-02

Ticker Symbols

Name	Symbol
SSE	688513.SS

More Shares

Investors who hold Chengdu Easton Biopharmaceuticals Co., Ltd. also have the following shares in their portfolio:

INVESTEC BANK PLC KO NTS CAR 11/03/25 Bond

TELECOM ITAL 21/29 MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog